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STING is an essential signalingmolecule for DNA and
cyclic di-GMP (c-di-GMP)-mediated type I interferon
(IFN) production via TANK-binding kinase 1 (TBK1)
and interferon regulatory factor 3 (IRF3) pathway. It
contains an N-terminal transmembrane region and
a cytosolic C-terminal domain (CTD). Here, we
describe crystal structures of STING CTD alone
and complexed with c-di-GMP in a unique binding
mode. The strictly conserved aa 153–173 region
was shown to be cytosolic and participated in dimer-
ization via hydrophobic interactions. The STING CTD
functions as a dimer and the dimerization was inde-
pendent of posttranslational modifications. Binding
of c-di-GMP enhanced interaction of a shorter
construct of STING CTD (residues 139–344) with
TBK1. This suggests an extra TBK1 binding site,
other than serine 358. This study provides a glimpse
into the unique architecture of STING and sheds
light on the mechanism of c-di-GMP-mediated
TBK1 signaling.
INTRODUCTION
A stimulator of interferon genes (STING) (Ishikawa and Barber,
2008; Ishikawa et al., 2009), also known as MITA (Zhong et al.,
2008, 2009), ERIS (Chen et al., 2011; Sun et al., 2009), MPYS
(Jin et al., 2008, 2010, 2011a, 2011b), and TMEM173, is known
to play a vital role in the production of type I IFNs (Barber,
2011; Bowzard et al., 2009; Ishikawa and Barber, 2011; Nakhaei
et al., 2010; Saitoh et al., 2010). The membrane protein STING
was initially characterized as a plasma membrane tetraspanner
associated with type II major histocompatibility complex
(MHC-II) with a function to transduce apoptotic signals during
antigen presentation (Jin et al., 2008). Subsequently, STING is
shown to reside predominantly in the endoplasmic reticulum
(ER) membrane, where it plays a role in relaying the intracellular
DNA-mediated innate signals to type I IFN (IFN-I) production
(Ishikawa and Barber, 2008; Ishikawa et al., 2009). STING-deficient (Tmem173/) cells are defective in IFN-I induction
triggered by viral, bacterial, or synthetic DNA and STING-
deficient mice are more sensitive than wild-type (WT) controls
when infected with DNA viruses such as HSV-1 (Ishikawa
et al., 2009).
Despite the essential role of STING in DNA-mediated IFN-I
induction, the mechanisms of its action are less clear and
controversial in some cases. First, STING is believed to function
as an adaptor molecule activated by cytoplasmic receptors after
sensing DNA. One potential cytoplasmic DNA receptor, DDX41,
has been shown to form a complex with STING and trigger
STING-dependent IFN-I induction (Zhang et al., 2011). However,
the nature of the interaction of STING with DDX41 is not known.
Another recent report indicates that STING can directly interact
with c-di-GMP (Burdette et al., 2011), a product released by
bacteria such as Listeria monocytogenes. In addition to ER
localization, some reports indicate that STING is also located
at the outer membrane of mitochondria whereas other studies
show that STING is translocated from ER to mitochondria during
viral infections (Zhong et al., 2008). Further, activated STING is
believed to mediate IFN-I induction through recruiting cytosolic
TANK-binding kinase 1 (TBK1), which phosphorylates and
activates interferon regulatory factor 3 (IRF3) (Sun et al., 2009).
However, it is still not clear how STING is activated and how
the activated STING triggers the recruitment and activation of
TBK1. Interestingly, STING is also subject to a broad range
of posttranslational modifications like phosphorylation and
ubiquitination by TBK1 and RNF5, respectively (Zhong et al.,
2008). Phosphorylation of STING at S358 by TBK1 is increased
after viral infection. This phosphorylation is not only critical for
the interaction of STING with TBK1 but also helps STING evoke
the immune response (Zhong et al., 2008). In addition, IFN-
inducible TRIM56 interacts with and facilitates lysine 63-linked
polyubiquitination at K150 of STING, which is proposed as
a prerequisite for the recruitment and activation of TBK1 to
STING and IFN-I induction after detection of a pathogen’s
double-strand DNA (dsDNA) (Tsuchida et al., 2010). This finding
raises an interesting question—howdoes TRIM56 gain access to
STING K150? TRIM56 is found in the cytoplasm and is known to
interact with the C-terminal domain (CTD) of STING spanning aa
174–379 (Tsuchida et al., 2010). The aa 153–173 region of STING
has been predicted to be a transmembrane region, suggestingImmunity 36, 1073–1086, June 29, 2012 ª2012 Elsevier Inc. 1073
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the membrane. If this is the case, then how does TRIM56
associate with STING across the membrane and carry out
ubiquitination? Another contradictory fact is that a K150R
STING mutant is shown to be incapable of associating with
TBK1 and is unable to activate the production of IFN-I (Tsuchida
et al., 2010). However, in a previous study the same STING
K150R mutant is proposed to activate IFN-stimulation respon-
sive element (ISRE) resulting in production of IFN-I (Zhong
et al., 2009).
Thus, mounting evidence reveals a central role for STING in
innate immune responses, prompting us to study its structure
and function. Here, we describe the crystal structures of
the STING CTD alone and in a complex with c-di-GMP refined
to 2.45 A˚ and 2.15 A˚ resolution, respectively. Our structural,
functional, and mutagenesis studies defined the dimer interface
of STING and characterized the structure of c-di-GMP bound
to the STING CTD. Insights into the understanding of c-di-
GMP-mediated TBK1 signaling are provided.
RESULTS
Crystallization and Structure Determination
of STING CTD
Full-length STING (aa 1–379) could not be expressed as a solu-
ble protein in E. coli. Our sequence analysis results showed
that the aa 153–173 region, reported as the last transmembrane
domain (Table S1 available online), is the most conserved region
in all species examined (Figures 1A, S1A, and S1B), suggesting
an important role for this region in the function of STING.
After expression screening of several N-terminal deletion
truncations (Figure 1B) in E. coli, truncations STINGD1-148
(aa 149–379) and STINGD1-138 (aa 139–379) could be expressed
as highly soluble proteins and purified to homogeneity with
excellent solution properties as stable homodimers (Figures 1C
and S1C).
STINGD1-138 (aa 139–379) (referred to as STING CTD
hereafter) crystallized in space group C2221. Se-Met derivative
of the proteins were used to determine the phases by Se-SAD
methodwith PHENIX (Figure S2; Adams et al., 2010). The phases
were transferred to a native data set (program CAD) and follo-
wed by density modification (program DM) and the model
was automatically traced by program Warp (Winn et al., 2011).
The best model derived from the native data was refined
to 2.45 A˚ resolution with PHENIX and Refmac (Adams et al.,
2010; Winn et al., 2011). All additional crystallographic statistics
were summarized in Table 1. Except for residues 139–151,
227–239, 319–320, and 344–370, the electron density was clear
and permitted unambiguous placement of residues. TheseFigure 1. Sequence Conservation of STING CTD, STING Domain Orga
(A) Alignment of the STING CTD domain sequences of representative STINGs
(NP_001039822), horse (XP_001504275), and pig (NP_001136310). Strictly cons
residues are boxed in red on a white background. The predicted last transmem
representation of the secondary structure elements of unliganded STING CTD a
generated by ClustalW (Thompson et al., 1994). The a helix is depicted by a coil an
(B) The schematic of human STINGdomain organization. The numbers indicate res
transmembrane domains of STING. The crystals were generated from aa 139–37
(C) His-tag removed STING CTD analyzed by analytical ultracentrifugation showmissing residues were located in the loop regions, suggesting
that they are mobile in the constructs used for this study.
To locate the missing residues, B-factor sharpening method
was attempted (DeLaBarre and Brunger, 2003; Su et al., 2010).
However, the weak electron densities could not be improved
any further.
Thus, construct boundaries based on the conserved regions
suggested by sequence alignment, rather than those based on
previously predicted transmembrane regions, resulted in protein
suitable for structure determination.
Overall Structure of STING CTD
Amino acids 152–343 folded into a single domain containing five
helices and five strands (Figure 2A). The N-terminal domain is
predicted to fold into four transmembrane helices, so the
numbering of helices in the STING aa 152–343 structure starts
with helix a5 (Figure 2A). Helices a5 and a6 (V155-N188)
form a long extended helix with only a tyrosine (T167) separating
them. Helix a6 is long and bends at P173 along the helical
axis, resulting in a change in the direction of the helix (Figure 2A).
Amino acids from helices a5 and a7 are involved in
intermolecular hydrophobic interactions. STING CTD contains
a single curved sheetmade up of five strands (Figure 2A). Helices
a7 and a8 are stacked against the sheet and are inserted
between helix a5 and the sheet. Interestingly, part of helix a9 is
buried in the concave cavity formed by the sheet (Figure 2A). A
number of salt bridges formed between three glutamic acid
and two arginine residues hold the helix a9 firmly inside the
cavity. Electron density for the C-terminal end of the protein,
aa 344–379, positioned at the end of helix a9 was missing,
suggesting that this part of the protein is flexible and probably
swings around the tip of helix a9 protruding out of the concave
cavity of the sheet.
A Dali (Holm and Rosenstro¨m, 2010) analysis retrieved a very
low structural match with leucine-rich repeat kinase 2 (PDB code
2ZEJ, Z score –4.4, rmsd of 4.0 A˚ for 162 matching residues
with 9% sequence identity). Similarly, a ProFunc (Krissinel and
Henrick, 2004) analysis retrieved matches for a small portion of
the protein with a number of GTP and DNA binding proteins.
However, the overall structure of STING CTD is unique and
does not resemble any structures deposited in PDB.
Previous studies propose that the STING aa 153–173
hydrophobic region constitutes the last transmembrane domain
(summarized in Table S1). From the structure of STING CTD
(aa 152–343), this region (aa 153–173) of STING is actually not
a transmembrane helix (Figure 2A). Instead, our studies suggest
that the STING aa 1–138 region is transmembrane with the
secondary structural elements threading the membrane four
times (Figure S1A).nization, and STING CTD Protein Characterization
from human (NP_938023), mouse (NP_082537), rat (NP_001102592), cattle
erved residues are boxed in white on a red background and highly conserved
brane domain is boxed in magenta. At the top of the sequences, a schematic
re shown, and every ten residues are indicated with a dot (.). Alignment was
d b strand by an arrow. The figure was generated by ESPript (Gouet et al., 1999).
idues at the domain boundaries. Amino acids 1–173 contains the predicted five
9 (green) and aa 152–343 (red) was observed in the final structure.
s dimeric STING CTD (55 kD) in solution.
Immunity 36, 1073–1086, June 29, 2012 ª2012 Elsevier Inc. 1075
Table 1. Data Collection and Refinement Statistics
Crystal STING CTD Se-Met STING CTD Native STING CTD:c-di-GMP Complex
Data Collection
X-ray source BL17U1, SSRF BL17U1, SSRF BL5.0.1, ALS
Detector ADSC 315 ADSC 315 ADSC 315
Crystal to detector distance (mm) 350.0 300.0 290.0
Number of images 260 612 180
Oscillation width () 1.0 0.5 1.0
Wavelength (A˚) 0.9793 0.9793 0.9793
Space group C2221 C2221 P21
Unit cell dimensions
a, b, c (A˚) 78.84, 88.53, 74.43 81.04, 90.36, 73.32 61.38, 72.84, 62.44
a, b, g () 90.00, 90.00, 90.00 90.00, 90.00, 90.00 90.00, 97.03, 90.00
Resolution range (A˚) 50.00–3.10 (3.21–3.10) 50.00–2.45 (2.54–2.45) 50.00–2.15 (2.23–2.15)
Rsym (%) 10.8 (52.4) 7.1 (49.6) 5.5 (39.5)
Mean I/sI (I) 39.2 (9.5) 56.9 (5.0) 23.5 (2.3)
Completeness (%) 99.9 (100.0) 99.9 (99.2) 96.9 (80.7)
Redundancy 9.8 (10.2) 11.3 (9.7) 3.6 (3.2)
Phasing
Phasing resolution (A˚) 50.00–3.10
Rano/Rp.i.m
a (50.00–3.10 A˚) 1.16
Number of Se located (occupancy) 1 (2.33)
Mean FOM 0.38
Refinement
Resolution (A˚) 45.18–2.45 41.01–2.15
No. reflections 10,182 29,026





Mean B value (A˚2) 68.59 56.69
Mean B value of protein (A˚2) 68.57 57.22
Mean B value of c-di-GMP (A˚2) 47.36
Rms deviations
Bond lengths (A˚) 0.007 0.008
Bond angles () 1.081 1.157
Ramachandran analysis
Favored region (%) 155 (92.26) 316 (93.77)
Allowed region (%) 10 (5.95) 12 (3.56)
Outliers (%) 3 (1.79) 9 (2.67)
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STING and c-di-GMP-Mediated TBK1 SignalingSTING CTD Forms a Unique Dimeric Structure
Although the asymmetric unit contained one molecule of STING
CTD, analysis of the symmetry mates revealed that unliganded
STING CTD had crystallized as a dimer, measuring 43 A˚ in
height and 37 A˚ in diameter (Figures 2B and 2C). Dimerization
occurs via an extensive hydrophobic interface, and the major
contact area spans 916.2 A˚2 (9.2%) of surface area permonomer1076 Immunity 36, 1073–1086, June 29, 2012 ª2012 Elsevier Inc.with calculated solvation free energy gain upon formation of the
interface (DiG) of 13.4 kcal/mol as determined by PISA (Krissinel
and Henrick, 2007). To rule out the possibility that dimerization
might have occurred as an artifact of crystallization, gel filtration
and analytical ultracentrifugation analysis were performed to
determine the oligomerization state of the protein. Results of
both the analyses showed that unliganded STING CTD exists
Figure 2. Crystal Structure of STING CTD Dimer
(A) Stereo view of STING CTD. Side view (parallel to the membrane) of cartoon representation of the overall structure of STING CTD monomer. b strands and
a helices are numbered. The conserved hydrophobic dimeric interface (aa 153–173), predicted as last transmembrane helix, is shown in magenta. The N and
C termini of each chain are labeled with letters. The missing residues are shown in dashed lines.
(B) Side view of the STING dimer. The yellow dashed line shows the hydroxyl group of Y274 interacting with the hydroxyl oxygen of Y164. Y164 and Y274 from two
monomers are shown as sticks. Interfacing residues identified by PISA (Krissinel and Henrick, 2007) are shown in cyan.
(C) Top view (perpendicular to membrane) of the STING dimer. Among the interfacing residues, highly conserved residues are shown as gray sticks. The 2-fold
symmetric axis, located in the middle of STING CTD dimer, is represented by oval dot.
(D) Residues (amaranth) of the dimer interface are highly conserved. Amino acid conservation of STING CTD via 17 homologs in Figure S1 displayed on a 3D
structure with ConSurf (Ashkenazy et al., 2010).
(E) A stereo view of the dimer interface from bottom view showing symmetry-related p-p stacking between P153 and H157 (cyan) and the aryl-sulfur interaction
between E161 and M271 (green). N termini are marked N.
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STING and c-di-GMP-Mediated TBK1 Signalingas a dimer in solution, which was consistent with the crystal
packing analysis (Figures 1C, 2B, and 2C). Thus, we conclude
that STING CTD exists as a homodimer in solution.
Within the dimer, STING CTD monomers were related by
a crystallographic 2-fold symmetry axis (Figure 2C). The 2-fold
axis was located near the junction of the two N-terminal a5helices. STING CTD dimerizes via helix-helix interactions, with
helices a5 and a7 predominantly involved in the intermolecular
interactions. Interestingly, residues from helix a5 are the most
conserved (Figure 2D), suggesting that the mode of dimerization
might be very similar across species. Hydrophobic amino acids
constituted about 65.5% of the total residues involved inImmunity 36, 1073–1086, June 29, 2012 ª2012 Elsevier Inc. 1077
Figure 3. c-di-GMP Binds into the Trough at the Dimer Interface
(A) The binary complex structure of STINGCTDwith c-di-GMP. c-di-GMP is shown as gray sticks. The STING dimer is shown in similar orientation as in Figure 2B.
(B) Close-up view of specific recognition of c-di-GMP by STING and details of hydrogen bonds%3.50 A˚. Shown are interactions between ribose-phosphate of
GMP and waters, as well as c-di-GMP and T263 from STING monomer A and B, respectively. Hydrogen bonding atoms between c-di-GMP and residues of
STING are connected by red dashed lines. Hydrogen bonds between c-di-GMP and waters are shown as black dashed lines. Residues from STING monomer A
and monomer B that interact with c-di-GMP are shown as green (with black labels) and cyan (with white labels) sticks, respectively. c-di-GMP is shown as yellow
sticks. Electron density of a SA (simulated annealing) Fo-Fc omit map for c-di-GMP contoured at 3.0 s. Water molecules are shown as red spheres with numbers
labeled.
(C) LIGPLOT representation of the STING CTD:c-di-GMP complex revealing bonding atoms and bonding lengths (Wallace et al., 1995). Interacting atoms are
connected by green dashed lines with bonding lengths indicated (in A˚). Nonligand residues involved in direct hydrophobic contacts with c-di-GMP are shown
Immunity
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STING and c-di-GMP-Mediated TBK1 Signalingdimerization (Table S2). A symmetry-related stacking interaction
between F153 of one chain with the H157 from the other chain
seems to stabilize the dimer (Figure 2E). In addition, a
symmetry-related aryl-sulfur interaction between the p-electron
cloud of the indole ring of W161 from helix a5 and the side chain
of M271 from helix a6 further contributed to the stabilization of
the dimer (Figure 2E). These amino acids are absolutely
conserved in STING from different organisms (Figures 1A and
S1A). A number of weak interactions were also observed
between helices a5 and a7. The dimer interface of STING CTD
was dominated by hydrophobic interactions with no salt bridges
participating in the dimerization. Thus, based on several lines of
evidence, we propose that STING CTD exists as a V-shaped
dimer even in the absence of a ligand.
c-di-GMP Binds into the Trough at the Dimer Interface
The structure of the binary complex of STING CTD with c-di-
GMP was determined in P21 space group by cocrystallizing
STING CTD with the nucleotide analog (Figure 3A). Clear elec-
tron density for the c-di-GMP permitted unambiguous modeling
of the nucleotide into the structure of STING CTD (Figure 3B).
Similar to the structure of unliganded STING CTD, several resi-
dues at the N terminus, the entire C-terminal region from aa
344 to 379, and the loops connecting strand b2 with b3 and b5
with helix a9 were disordered (Figure 3A). One molecule of
c-di-GMP bound a dimer of STING CTD. Thus, a dimer seems
to be the minimal functional unit of STING as shown in Figure S3.
Overall, the structure of the c-di-GMP-bound STING CTD
closely mirrored the unliganded structure (with rmsd 0.64 A˚
over main chain atoms between one monomer) with an almost
identical dimer interface (Figure S4A). One molecule of c-di-
GMPbound into the trough formed at the junction of dimerization
where its innate 2-fold symmetry axis was coaxial with the
noncrystallographic 2-fold symmetry axis of the STING CTD
dimer (Figure 3A). This resulted in nearly symmetrical interac-
tions for the ribose-phosphate ring with the STING CTD dimer
(Figure 3B). Interestingly, the loop connecting strand b2 with
b3 remained disordered after binding of c-di-GMP (Figure 3A).
Visual inspection of the superimposition of the unliganded and
c-di-GMP complex structures revealed that except for some
minor changes, therewere no obvious structural rearrangements
induced as a result of binding of c-di-GMP. Positions of the loop
connecting helix a6 with strand b1 (residues A302-N307) and the
region connecting helix a8 with strand b5 (residues N183-A192)
seemed to have deviated slightly in the binary complex. Further,
strands b2 and b3 (residues F221-Q227 and S241-Y245)
together with the disordered loop connecting them had moved
toward c-di-GMP upon its binding to STING CTD. Intriguingly,
the movements of those two b strands were asymmetrical
between monomer A and monomer B. The two b strands in
monomer A were closer to the guanine moiety than that seen
in monomer B when monomer B was superimposed onto
monomer A as shown in Figure S4B. We still do not know why
and how c-di-GMP induces such asymmetry, albeit minor,as red semicircles with radiating spokes, and those indirectly involved are sh
labeled.
(D) Stereographic close-up view of the c-di-GMP binding site and details of hydro
from STING monomer A (top) and monomer B (bottom), respectively.between the two monomers and what is the physiological
significance of such a deviation observed in the structure.
Such asymmetry has been reported previously for a c-di-GMP
riboswitch (Smith et al., 2009).
The c-di-GMP was seen anchored to the protein mainly by
several hydrogen bonding and hydrophobic interactions
(Figure 3C; Table S3). The interaction between ribose-phosphate
of GMP with STING CTD was more symmetrical than that of the
guanine with STING CTD (compare Figure 3B and Figure 3D).
There were four hydrogen bonds (%3.5 A˚) between the ribose-
phosphate ring and STING CTD: two pairs formed between O2
of ribose and OG1 of T263 and two pairs formed between O3
of ribose and OG1 of T267 via a water molecule (water 26 and
52, respectively) (Figure 3B). Interestingly, the phosphates
neither were involved in hydrogen bonding nor were anchored
by any basic side chains (Figure 3B). The interactions of the
two guanines with STING CTD monomers were more deviated
from the 2-fold symmetry axis. Both purine rings of c-di-GMP
were stacked against the aromatic ring of Y167 (Figures 3B
and 3D). OG1 atoms of T263 from two monomers were interact-
ing with N3 and N31 atoms of c-di-GMP via hydrogen bonds,
3.02 and 2.96 A˚, respectively (Figure 3B). Both amine nitrogen
atoms (N21 and N2) of GMP were anchored by hydrogen bonds
with two water molecules (water 1 and 9), which formed
hydrogen bonds with residues Y163, Y261, and E260 on the
other side (Figures 3C and 3D). These two water molecules
were observed in unliganded STING CTD crystal structure as
well. These water-mediated hydrogen bonds probably make
STING prefer c-di-GMP over c-di-AMP because c-di-AMP
does not have the amine group of GMP (Figure S4C). Intriguingly,
two extra hydrogen bonds between guanine and two water
molecules (water 2 and 3), which were mediated through
hydrogen bonds by main chain nitrogen and oxygen atoms of
S241 of monomer A, were observed (Figure 3D, top). Such extra
hydrogen bonds were not observed in monomer B (Figures 3C
and 3D, bottom; Table S3). Further, two additional residues
(R238 and V239) from monomer A became ordered as a result
of the c-di-GMP binding (Figure 3D, top). In addition, Y240’s
side chain swung toward c-di-GMP as shown in Figure 3D
(top). These changes upon binding of c-di-GMP were not
observed in monomer B.
Thus, binding of c-di-GMP does not induce large conforma-
tional changes in STING CTD. Upon close inspection of the
c-di-GMP-bound STING, some asymmetrical interactions of
STING with the purine rings of c-di-GMP were observed.
c-di-GMP was anchored on STING by a combination of hydro-
philic, hydrophobic, and water-mediated contacts.
Requirement of STING Self-Association
for IFN-b Induction
It has been reported that STING dimerization is responsible for
self-activation and subsequent downstream signaling (Sun
et al., 2009). However, the nature of the intermolecular interac-
tions and whether STING dimerization is required for IFN-Iown as blue circles. Water atoms are shown in gray spheres with numbers
gen bonds between c-di-GMP and waters, as well as c-di-GMP and residues
Immunity 36, 1073–1086, June 29, 2012 ª2012 Elsevier Inc. 1079
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our crystal structure to first identify the key residues involved
in dimerization and mutated them to disrupt the dimerization
of STING. The following mutations were selected: V155R,
G158L, W161A, Y164A, and I165R. All the mutants were ex-
pressed in E. coli with an N-terminal 6His tag. Mutants V155R,
W161A, and Y164A were insoluble even when salvaged with
an N-terminal GST tag (Figure S5A), suggesting that these
mutations probably disrupt the dimerization interface and
expose the hydrophobic patches resulting in precipitation of
the proteins. The soluble G158L and I165R mutants were further
purified by Ni affinity followed by gel filtration chromatography.
The size exclusion chromatography (SEC) profile of the mutants
indicated a highly aggregated protein when compared to the
STING CTD WT. Part of the G158L mutant eluted similar to the
STINGCTDWT, suggesting that a small portion of G158Lmutant
remained dimeric (Figure 4A).
To test whether the integrity of the dimer of STING was
essential for its function, we performed luciferase reporter assay
on the full-length mutants and the STING WT in 293T cells. The
V155R, W161A, and Y164A mutations of the full-length STING
showed no activity as expected. Further, the I165R mutant that
could be expressed as soluble protein in E. coli was inactive.
The G158L mutation showed partial activity when compared to
the STINGWT (Figure S5B). To further investigate, we performed
coimmunoprecipitation assay in 293T cells coexpressing Flag-
tagged STING and HA-tagged STING or HA-tagged STING
G158L. Although STINGWT interacted strongly with each other,
the STING G158L mutant dramatically lost its ability to interact
with WT STING and with G158L mutant itself (Figure S5C),
corroborating the results of the gel filtration chromatography
and the luciferase reporter assay experiments.
A recent study shows that an IFN-inducible tripartite-motif
protein (E3 ligase TRIM56) carries out ubiquitination of STING
when stimulated by poly(dA:dT). Ubiquitination of STING at
K150 results in the dimerization of STING, which is a prerequisite
for the recruitment and activation of TBK1 leading to the
induction of IFN-I (Tsuchida et al., 2010). However, based on
our structure of the STING dimer, K150 may not play a major
role in the dimerization of STING. To test this, we expressed
and purified the STING CTD K150A, K150L, and K150R mutants
and carried out SEC to determine the oligomerization state of the
protein. The results revealed that similar to the STING CTD WT,
the mutants existed as dimers in solution (Figure 4B). Next, to
characterize the importance of K150 for STING dimerization
in vivo, we generated K150A, K150L, and K150R mutants of
full-length STING in 293T cells. As shown in Figure 4C, all three
mutant K150 proteins could bind STING-HA as strongly as did
STING-Flag. These results demonstrate that K150 may not be
essential for dimerization of STING.
To determine whether the dimerization-deficient mutant had
a defect in triggering downstream signaling, we performed lucif-
erase reporter assay in 293T cells expressing STING WT and
STING G158L, K150A, K150L, and K150R mutants. Whereas
STING WT and STING K150A, K150L, and K150R mutants
induced strong activation of the IFN promoter (IFN-b-Luc),
the activation of IFN-b-Luc by STING G158L was significantly
reduced (Figure 4D, p < 0.01). To confirm that STING dimeriza-
tion was required for induction of IFN-I, we generated STING-1080 Immunity 36, 1073–1086, June 29, 2012 ª2012 Elsevier Inc.deficient (Tmem173/) murine embryonic fibroblasts (MEFs)
reconstituted with vector, STING WT, and STING G158L and
K150R mutants. After transfection of B-DNA, IFN-b production
in MEFs was examined by quantitative real-time PCR (Q-PCR).
STING deficiency caused a dramatic loss of IFN-b production
compared to WT MEFs (Figure 4E, p < 0.01). Reconstitution of
STING-deficient MEFs with STING WT and K150R rescued
B-DNA-induced IFN-b production, whereas reconstitution with
STINGG158Lmutant failed to do so (Figure 4E, p < 0.01). Similar
results were obtained for Cxcl10 (Figure 4F, p < 0.01).
Next, we carried out GST pull-down assays to test the
association of STING CTD K150R, K150L, and K150A with
TBK1. In addition, we also tested whether G158L, S358A, and
a truncated STING containing 139–344 amino acids could
associate with TBK1. Both STING CTD WT and the three STING
CTD K150 mutants could interact directly with TBK1 (Figure 5A).
To confirm the interaction in cells, we performed coimmunopre-
cipitation assay in 293T cells expressing HA-tagged STING and
Flag-tagged TBK1 and showed that TBK1 immunoprecipitated
together with STING (Figure 5B). The other two kinases involved
in DNA virus-induced IFN-b production, IKKa and NIK, did not
interact with STING (Figure 5B). Surprisingly, the three mutants
K150A, K150L, and K150R and the dimerization-deficient
G158L interacted with TBK1 in amanner similar to the interaction
of STINGWTwith TBK1 (Figure 5C), suggesting that dimerization
of STING may not be absolutely required for interaction with
TBK1. Further, the truncated STING (aa 139–344) and the
S358A mutant showed comparatively weaker interaction with
TBK1 (Figure 5A). More importantly, the inability of dimeriza-
tion-deficient STING G158L to induce IFN production (Figure 4E)
in spite of retaining its TBK1 binding ability (Figure 5C) suggests
that only the dimerized STING-TBK1 interaction can induce
IFN-b production.
Human STING CTD Binds c-di-GMP, Resulting
in Enhanced Recruitment of TBK1
Recently, the mouse STING was shown to bind c-di-GMP,
resulting in the induction of IFN (Burdette et al., 2011). Based
on this result, STING is proposed to function as the sensor in
inducing a STING-dependent IFN-I response. Human STING
shares about 70% sequence homology with its counterpart
frommouse (Figures 1A and S1A). To test whether human STING
could interact with c-di-GMP, we performed binding studies.
ITC and thermal shift assay results showed that human
STING bound c-di-GMP with an affinity of 4.4 mM (Figure 6A).
Both ITC and thermal shift assays could not detect binding of
c-di-AMP with STING (Figures 6B and S6A; Table S4). In
addition, human STING did not bind GTP or dGTP (Figure 6B).
Unlike phosphodiesterase (PDE) (Christen et al., 2005; Minasov
et al., 2009), cations, such as Mg2+, were not required for
c-di-GMP binding to STING (Figure 6B), which was consistent
with the fact that we could not detect any well-ordered cations
associated with c-di-GMP in the complex structure. Further,
STING mutants K150R, K150L, K150A, S358A, and a shorter
truncation aa 139–344 (G344) bound c-di-GMP similar to STING
WT. However, G158L and I165R mutants lost their c-di-GMP
binding ability as suggested by thermal shift assays (Figure S6B
and Table S4). These mutagenesis results can be explained by
inspecting the STING CTD:c-di-GMP complex structure. K150
Figure 4. The Screening of Dimerization-Deficient Mutants
(A) Gel-filtration chromatography of STINGCTDWT andG158L and I165Rmutants. STINGCTDmutants S358A andG344 (aa 139–344) were used as control. The
profile of STING CTD WT is used as the marker. The proteins were analyzed by Superdex G75 (120 ml) gel-filtration chromatography. The calculated molecular
masses of the monomeric human STING WT and G344 mutant with His-tag are 30 kD and 26 kD, respectively.
(B) Gel-filtration chromatography of STING WT and K150R, K150L, and K150A. The proteins were analyzed by Superdex G75 (120 ml) gel-filtration
chromatography.
Asterisks indicate degraded STING bands (A, B).
(C) Coimmunoprecipitation of cell lysates fromHEK293T cells expressing STING-Flag and STING-HA or STINGG158L-HA. Lysates were incubatedwith anti-Flag
M2 beads and STING self-association was detected by immunoblot analysis against HA.
(D) IFN-b reporter activity of 293T cells expressing STING WT or STING G158L.
(E) Quantitative real-time PCR analysis of relative IfnbmRNA after transfection of B-DNA inWTMEFs (WT), Tmem173/MEFs, Tmem173/MEFs reconstituted
with STING (Tmem173/ + STING WT), or Tmem173/ MEFs reconstituted with STING G158L (Tmem173/ + STING G158L).
(F) Quantitative real-time PCR analysis of relative Cxcl10 mRNA after transfection of B-DNA in WT, Tmem173/, Tmem173/ + STING WT, or
Tmem173/ + STING G158L MEFs.
Double asterisks (**) indicate significant difference (p < 0.01) as determined by Student’s t test. Error bars indicate SEM.
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Figure 5. Requirement of STING Self-Association for IFN-b
Induction
(A) Interaction of STING with TBK1 by GST pull-down. GST and GST fusion
protein (STING CTD mutants) were expressed in E. coli and conjugated to
glutathione-agarose beads and incubated with 1.65 mg of recombinant TBK1
in a final volume of 1.0 ml of PBS (137.0 mM NaCl, 2.7 mM KCl, 50.0 mM
Na2HPO4, 10.0 mM KH2PO4 [pH 7.4]) with 2 mM DTT, 1 mM EDTA, and 1%
Nonidet P-40 followed by 5 times wash and immunoblotting with Flag
antibodies.
(B) Interaction of STING-HA with Flag-TBK1, Flag-IKKa, or Flag-NIK in 293T
cells. Cell lysates were immunoprecipiated with anti-HA beads followed by
immunoblotting with indicated antibodies.
(C) Interaction of Flag-TBK1 with STING or STING G158L in 293T cells. Cell
lysates were immunoprecipiated with anti-HA beads followed by immuno-
blotting with indicated antibodies.
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GMP. On the other hand, G158 and I165 are part of the dimer
interface and are essential for the formation of the c-di-GMP
binding pocket.
Next, based on the structure of the binary complex,
we mutated residues surrounding c-di-GMP to perturb the
binding of the nucleotide analog. c-di-GMP binding ability of
STINGcouldbecompletely abolishedbymutatingS162 to a tyro-
sine or glutamic acid (Figures S6C and S6D). S162 was located
below the ribose ring, in proximity to the phosphate group of
c-di-GMP. A longer or wider side chain probably obstructs the
docking of c-di-GMP into the binding pocket (Figure S6E).
When overexpressed in 293T cells, the STING S162Y mutant
induced much lower levels of IFN-b than did STING WT, high-
lighting the importance of this residue in STING-mediated type
I interferon production (Figure S6F). In contrast, mutating T263
to arginine increased the c-di-GMP binding affinity (0.461 ±
0.053 mM) by about 10-fold (compare Figures 6A and 6C). This
mutation increased the c-di-AMP binding affinity of STING to1082 Immunity 36, 1073–1086, June 29, 2012 ª2012 Elsevier Inc.8.20 ± 0.553 mM, which was about one half of the affinity of
STING WT for c-di-GMP (Figure 6D). The side chain of T263
pointed toward one side of guanine, and the other side was
stacked against the aromatic ring of Y167 (Figures 3B and 3D).
The mutated longer arginine side chain, together with Y167,
sandwiched guanine in the middle, which probably increased
STING CTD’s affinity for c-di-GMP or c-di-AMP. Mutating Y167
(seen stacked against the guanine ring) to serine resulted in an
insoluble protein. I200N mutant of STING has been previously
shown to be unable to bind c-di-GMP (Burdette et al., 2011;
Sauer et al., 2011). We attempted to bacterially express STING
I200N via different strategies without success, which was
consistent with the prediction by SDM server that this mutant
was highly unstable (Worth et al., 2011). Mutating Y240 to
alanine, histidine, phenylalanine, or tryptophan had no obvious
effect on c-di-GMP binding. Thus, structure-based mutagenesis
confirmed an essential role for highly conserved residues like
S162, Y167, and T263 in binding c-di-GMP.
How binding of c-di-GMP elicits IFN production by STING is
currently unknown. Because TBK1 is central to the activation
of NF-kB and IRF3 signaling pathways, we studied the binding
of TBK1 with STING in presence of c-di-GMP by using
GST pull-down assays. STING interacted more strongly with
TBK1 in presence of c-di-GMP than with STING alone
(Figure 6E). Although c-di-AMP also increased the association
of TBK1 with STING, its effectiveness was much lower than
that of c-di-GMP. TBK1 is known to phosphorylate STING at
S358. To find out whether there were additional TBK1 binding
sites on STING, we carried out GST pull-down assays by using
truncated STING containing residues 139–344 only. Surprisingly,
the truncated STING bound TBK1 strongly in the presence of
c-di-GMP, suggesting the presence of additional TBK1 binding
sites on STING (Figure 6E). Taken together, these results
showed that upon binding c-di-GMP, recruitment of TBK1 was
enhanced. TBK1 was recruited to a new site that did not involve
S358. Thus, phosphorylation of S358 is probably not required for
IFN-I production elicited by c-di-GMP.
DISCUSSION
Several aspects of the structure-function studies on STING
produced unexpected results. Our initial attempts to express
truncations of STING around the previously predicted soluble
domain (aa 174–379) in E. coli as stable soluble protein failed.
When the highly conserved, predicted last transmembrane
domain (aa 153–173) was included in the truncations, a highly
soluble and stable STING CTD could be produced. Purified
STING CTD preferred to stay dimeric in solution. This result
provided a clue that STINGmight exert its function via homotypic
interactions in a manner similar to the symmetric dimerization of
TIR domains of TLR10 and MyD88 (Monie et al., 2009). The
structure of STING CTD provided evidence of a symmetric
homotypic interaction and defined the interface of the interac-
tion. The structure of STING CTD does not resemble any known
adaptors or proteins involved in innate immune responses and
has no structural homologs in PDB.
Although there is a general consensus on the presence of
a transmembrane region at the N terminus of STING, the
boundaries and the number of transmembrane passes reported
Figure 6. STING CTD Binds c-di-GMP and Enhances Recruitment of TBK1
(A) ITC titration curves of STING with c-di-GMP. Top, raw data of heat changes upon addition of c-di-GMP (500 mM) into the cell containing 50 mM of STING CTD
protein. Bottom, processed data corresponding to the heat of each injection plotted against themolar ratio of total c-di-GMP to total STINGCTD after subtraction
of the heat of control. The affinity constant (KD = 4.42 ± 0.02 mM) was derived at 2:1 fixed stoichiometry.
(B) The interaction of STING with c-di-GMP and c-di-AMP detected by thermal shift assay. GTP and dGTP were used as negative controls.
(C) The affinity of STING T263R with c-di-GMP is about 10 times higher than that of STING WT with c-di-GMP as estimated by ITC.
(D) The affinity of STING T263R and c-di-AMP increases to about one half of WT STING and c-di-GMP as estimated by ITC.
(E) Interaction of STING with TBK1 enhanced by c-di-GMP binding to STING. GST pull-down assays were performed in the same way as in Figure 5A.
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STING and c-di-GMP-Mediated TBK1 Signalingfor STING are variable. All the reports are in agreement with the
proposition that the region encompassing aa 153–173 is the last
transmembrane domain. Our structure of STING CTD reveals
that this region is cytosolic and part of the dimerization interface.
Thus, our structure of STING CTD redefines the boundaries of
the transmembrane region of STING. However, it is unclear
whether the current structure can formally exclude the possibility
that the a5 helix could insert into the membrane in the full-length
STING protein and/or mediating STING dimerization in the
membrane, although such dramatic conformational changes
may not be thermodynamically favorable.
The purified STING K150A, K150L, and K150R mutants
exhibited a dimeric assembly in solution and retained their
wild-type ability to bind TBK1 and stimulate IFN production as
indicated by GST pull-down studies and luciferase reporter
assay results. Thus, from our structural and functional data
it seems that the minimum physical and functional unit of
STING is a dimer because of the presence of a large hydrophobic
patch that can be solvent excluded only via dimerization.
Further, although a majority of the STING homologs have lysine
at position 150, some of the homologs (for example the horse
STING) do not have lysine in this position, suggesting that a lysine
at position 150 may not be essential for the function. Taken
together, these results suggest that ubiquitination of K150 may
neither be a prerequisite for dimerization of STING nor necessary
for association with TBK1.
Previously, STING has been shown to function as a dimer.
By using the structure of dimeric STING CTD, we selected resi-
dues for a mutation to disrupt the dimer interface, expecting
a loss of function of IFN induction. V155R, W161A, and Y164A,
mutants resulted in a complete loss of function of STING. Dimer-
ization-deficient G158Lmutant showed partial activity. Thus, our
structure-based mutagenesis data support the inference that
dimerization of STING is essential for induction of IFN.
c-di-GMP was first reported by Benziman and coworkers as
an allosterical activator in the membrane-bound cellulose
synthase of Gluconacetobacter xylinus in 1987 (Ross et al.,
1987). c-di-GMP is a ubiquitous second messenger that orches-
trates the motile planktonic and sedentary biofilm-associated
bacterial ‘‘lifestyles’’ (Hengge, 2009). STING CTD has been
shown to specifically recognize c-di-GMP (Burdette et al.,
2011) but not GTP or ATP. Inspection of the binary complex
of STING CTD with c-di-GMP revealed that there was no
space to accommodate the second or third phosphate group
of ADP/GDP or ATP/GTP. Therefore, STING has the ability to
discriminate between c-di-GMP and host GTP or ATP mole-
cules. Bacteria are also known to use c-di-AMP as a secondary
messenger molecule for signaling (Ro¨mling, 2008). Such
signaling molecules are not present in humans and therefore
the human body can sense intrusion by the immunosurveillance
pathway. Our structural analysis showed that c-di-AMP could be
docked at the same site as c-di-GMP without any steric
hindrance as a result of their structural similarity. c-di-AMP
does not have the amine group of c-di-GMP that is involved in
hydrogen bonding with a ‘‘conserved’’ (present in unliganded
structure) water molecule. This could explain why STING has
stronger binding affinity with c-di-GMP over c-di-AMP. In
addition, c-di-AMP has an amino group at C6 position that is
opposite in charge to the keto group seen in c-di-GMP, which1084 Immunity 36, 1073–1086, June 29, 2012 ª2012 Elsevier Inc.could further influence the binding of c-di-AMP to STING. In
fact, ITC and thermal shift assays did not detect any binding of
c-di-AMP with STING. However, mutating T263 to arginine
resulted in an affinity for c-di-AMP similar to that seen for c-di-
GMP with STING CTD WT. Clearly, further studies are needed
to ascertain whether STING signaling is c-di-GMP specific or
can be triggered by c-di-AMP too. To find out how binding of
c-di-GMP to STING resulted in initiation of downstream events
leading to IFN-I production, we compared the structure of
the c-di-GMP-bound STING CTD with the structure of the
unliganded STING CTD. Surprisingly, comparison of the struc-
tures revealed no large-scale conformational changes in STING
CTD upon c-di-GMP binding. So far, two different mechanisms
of activation via c-di-GMP are known (Schirmer and Jenal,
2009). One mechanism involves crosslinking domains. For
example, c-di-GMP has been shown to exert its effect by cross-
linking domains in PleD (Chan et al., 2004), DgcA (Christen et al.,
2006), and WspR (De et al., 2008). The second mechanism
involves signal-dependent ordering of loops. For example, an
NMR study on the PilZ domain containing protein PA4608
revealed that upon binding c-di-GMP, an N-terminal region
became ordered (Habazettl et al., 2011). Because dimerization
of STING is not signal dependent, we looked at disordered loops,
especially the loop connecting strand b2 with b3. This loop
was disordered in all the structures of STING CTD we solved.
c-di-GMP binds in proximity; in fact, this loop became partially
ordered and moved closer toward c-di-GMP upon its binding.
It is tempting to speculate that binding of c-di-GMP to STING
CTD makes these this loop more accessible for TBK1 binding.
This is partly supported by the fact that recruitment of
TBK1 was enhanced in the presence of c-di-GMP. Further
studies are warranted to explore this exciting possibility, which
would also shed light on whether STING plays distinct roles in
c-di-GMP and viral DNA-mediated signaling.
In summary, our structural, functional, and mutagenesis data
unravel several hitherto unknown aspects of STING. STING
forms homotypic interactions that are essential for stimulation
of IFN production. The structures of STINGCTD provide detailed
molecular insights into the nature of this homotypic architecture.
Notably, the structure of STING CTD is very different from any
known structure of adaptors or proteins functioning in innate
immune responses and therefore STING may represent a novel
class of sensors involved in detection of bacterial intrusion.
Our protein expression, analytical, and structural evidences
revealed that the aa 153–173 region was not a transmembrane
region as predicted previously but is a hydrophobic dimer inter-
face. The structure of the binary complex maps the exact
location of the c-di-GMP binding site on STING and unveils
a unique mode of binding of c-di-GMP to proteins. Structure-
guided mutagenesis studies showed that STING exists and
functions as a dimer. Further, ubiquitination of K150 may not
be a prerequisite for dimerization. The c-di-GMP binding pocket
is formed via dimerization of STING. We show that binding of
c-di-GMP enhances the association of TBK1 with STING.
An additional TBK1 binding site, other than the previously
reported S358, is probably responsible for c-di-GMP-mediated
TBK1 signaling. Although the results further our understanding
of the nature of the homotypic interactions of STING essential
for stimulation of IFN production, questions on how the signal
Immunity
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of downstream effector molecules, remain to be investigated.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Human STING fragments were amplified from a human transcription library
(Stratagene, USA) and cloned into pMCSG7 vector (Stols et al., 2002) for
expression in E. coli BL21 (DE3). The recombinant protein was purified by
Ni-affinity chromatography (QIAGEN, USA) and gel filtration chromatography
as described (Liang et al., 2011).
Crystallization and Data Collection
The initial crystallization conditions were examined with commercially
available sparse-matrix screening kits. Hits were optimized by hand. 2 ml
hanging drops containing 1 ml protein mixed with 1 ml mother liquor were
equilibrated over 300 ml reservoir solution and incubated at 16C. The STING
CTD and c-di-GMP complex was formed by mixing equal molar amounts of
STING CTD with c-di-GMP (Biolog, USA) with the same crystallization condi-
tion as unliganded STING CTD.
Structure Determination and Analysis
Diffraction data for Se-Met, native, and the binary complex of STING CTD
with c-di-GMP were collected at wavelength of 0.9793 A˚. Data were indexed
and scaled with HKL2000 (Otwinowski and Minor, 1997). The initial phases
were determined by Se-SAD (single-wavelength anomalous dispersion)
method (Hendrickson, 1991). PHENIX AutoBuild was used to rebuild themodel
with the initial phase (Terwilliger et al., 2008). Other structures were solved by
molecular replacement method with program Phaser (McCoy et al., 2007).
The models were manually improved in Coot (Emsley and Cowtan, 2004).
RefinementwascarriedoutwithREFMAC (Murshudovet al., 1997) andPHENIX
(Adamset al., 2010) alternately. The quality of the finalmodel was validatedwith
MolProbity (Chen et al., 2010). Structures were analyzed with PDBePISA
(Protein Interfaces, Surfaces, and Assemblies) (Krissinel and Henrick, 2007),
Dali (Holm and Rosenstro¨m, 2010), and ProFunc (Laskowski et al., 2005).
Immunoblotting and Immunoprecipitation
HEK293T cells were transfected with indicated plasmids with Lipofectamine
2000. 48 hr posttransfection, cells were homogenized. Cell lysates were
then incubated with anti-Flag M2 affinity gel or anti-HA affinity gel (Sigma)
for 2 hr at 4C and the immunoprecipitated complexes were separated by
SDS-PAGE and blotted with indicated antibodies.
IFN-b Luciferase Reporter Assay
HEK293T cells were transfected with IFN-b firefly luciferase and renilla
luciferase reporter plasmids together with STING WT or STING mutants.
48 hr posttransfection, firefly and renilla luciferase activities were determined
by a Dual Luciferase Assay System (Promega) and a SIRIUS Luminometer
(Berthold Detection Systems) according to the manufacturer’s protocol.
Additional Methods
More detailed descriptions of methods for protein expression and purification,
protein crystallization, structure refinement and analysis, cells and reagents,
real-time quantitative PCR, isothermal titration calorimetry (ITC), GST pull-
down, thermal shift, analytical ultracentrifugation, and statistical analysis can
be found in the Supplemental Information.
ACCESSION NUMBERS
Coordinates and structure factors for the unliganded and liganded STINGCTD
have been deposited in the Protein Data Bank under the accession codes
4EF5 and 4EF4, respectively.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and four tables and can be found with this article online at
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